SUBSCRIBE
SUBSCRIBE

Rezolute, Inc.

NEWS
BioForest
Clinical Catch-Up: May 25-29
In the lead-up to the ASCO Annual Meeting, companies were presenting some of their trial data, while other companies were presenting news related to COVID-19 studies. Here’s a look.
May 29, 2020
 · 
10 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
December 4, 2024
 · 
5 min read
Press Releases
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
November 8, 2024
 · 
6 min read
Press Releases
Rezolute to Participate in Upcoming November 2024 Investor Conferences
November 6, 2024
 · 
1 min read
Business
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
September 19, 2024
 · 
8 min read
Press Releases
Rezolute to Participate in Upcoming Investor Conferences
August 27, 2024
 · 
1 min read
Press Releases
Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
August 5, 2024
 · 
5 min read
Press Releases
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 31, 2024
 · 
1 min read
Pharm Country
Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 27, 2024
 · 
4 min read
Pharm Country
Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
June 24, 2024
 · 
4 min read
Pharm Country
Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
June 13, 2024
 · 
4 min read
Load More